Ending stigma PrEP When your job is to confront HIV stigma and combat PrEP misinformation March 2, 2020 I’ve been doing HIV prevention work for about 15 years For the last three, it’s been as a...
PrEP Research Treatment What we know about Descovy’s impact on weight & cholesterol January 8, 2020 Tenofovir alafenamide (TAF), co-formulated with emtricitabine in the combination pill Descovy...
Our impact PrEP Advancing policies to solve PrEP access issues October 22, 2019 Last year, our PrEP team began to notice an issue that was preventing timely access to PrEP...
PrEP FDA approves Descovy (F/TAF) for PrEP October 11, 2019 Seven years after Truvada (F/TDF) was approved for HIV prevention as PrEP, we now have...
PrEP Truvada Lawsuit Ads are Misleading October 9, 2019 You may have seen ads about a product liability lawsuit against Gilead Sciences, the makers...
PrEP Research 34% of transmasculine people given PrEP info by providers September 25, 2019 Although oftentimes overlooked in HIV and PrEP public health efforts, transmasculine...
PrEP Research IAS 2019 – PrEP use by transmasculine & transfeminine folks: New data from Northern California July 24, 2019
PrEP Research No effect of cocaine and PrEP on kidneys, but adherence suffers June 21, 2019 Men who have sex with men and trans women report higher levels of cocaine, meth and other...
Health policy PrEP New Policies to Improve PrEP Access June 18, 2019 As pre-exposure prophylaxis (PrEP) gains acceptance, medical experts and policymakers are...
Advocacy PrEP Press releases USPSTF Recommendation for PrEP June 11, 2019 SAN FRANCISCO, June 11, 2019--Today, the United States Preventive Services Task Force...
PrEP Prevention Sexual health PrEP 2-1-1 offered at Magnet April 3, 2019 For the first time in the US, PrEP “on-demand” dosing is being offered routinely at the...
PrEP Prevention Research New research: Is Descovy a new option for PrEP? March 6, 2019 Long-awaited results from a three-year PrEP clinical trial evaluating a new candidate...
PrEP Prevention U=U New research: Awareness, perceived effectiveness of U=U and intermittent PrEP low among MSM in New York City February 26, 2019 PrEP and treatment as prevention (TasP) are empowering people of any HIV status to live...
PrEP Prevention Research Low PrEP awareness and use among cis women seeking STI services February 19, 2019 In the US nearly 20% of new HIV infections are among cisgender women (cis women) with higher...
PrEP Prevention PrEP home delivery study brings PrEP to young men of color January 8, 2019 The small group of young men who took part in a recent PrEP study by a group of California...
PrEP Research For people having anal sex, PrEP 2-1-1 is effective at preventing HIV December 19, 2018 Daily use of PrEP reduces the risk of HIV infection by up to 99% Yet there are a few factors...
Harm reduction Our impact PrEP Sexual health Strut evaluation report: More diversity, improved outcomes, and more room to grow November 28, 2018 Jared Hemming, site director of Strut, the San Francisco AIDS Foundation’s health and...
PrEP Covered California for HIV, hep C meds and PrEP November 5, 2018 People in California looking for health insurance have until January 15, 2019 to sign up for...
PrEP Prevention Research Sixth case of rare PrEP failure reported—here’s what to know. October 5, 2018 In San Francisco, the sixth case of PrEP failure in a patient with high adherence was...
PrEP Prevention Research Hormone levels not affected by PrEP in trans women August 13, 2018 Using PrEP for HIV prevention does not lower levels of feminizing hormones, and hormones only...
PrEP Prevention PrEP scales up, HIV incidence declines August 8, 2018 As use of PrEP continues to grow, epidemiological evidence is starting to show a link between...
Ending stigma PrEP Sexual health Even with PrEP, HIV stigma & discrimination is still a thing April 9, 2018 I remember feeling confused and angry the first few times I was blocked or rejected by an...
PrEP Prevention Research PrEP use since 2012 is up, but uptake falls short of need April 4, 2018 The number of people using tenofovir/emtricitabine (Truvada) for PrEP exceeded 77,000 in...
